Download Citation
Article Source:
Cost-Effectiveness of Dabigatran versus Genotype-Guided Management of Warfarin Therapy for Stroke Prevention in Patients with Atrial Fibrillation
You JHS,
Tsui KKN,
Wong RSM,
Cheng G
(2012)
Cost-Effectiveness of Dabigatran versus Genotype-Guided Management of Warfarin Therapy for Stroke Prevention in Patients with Atrial Fibrillation.
PLOS ONE 7(6): e39640.
https://doi.org/10.1371/journal.pone.0039640